首页 › 基金 › STEMPOINT CAPITAL LP › MNPR

STEMPOINT CAPITAL LP 对 MNPR 的持仓历史

MONOPAR THERAPEUTICS INC · 医疗保健

STEMPOINT CAPITAL LP 在 Q2 2026 的 13F 申报中披露持有 MNPR(MONOPAR THERAPEUTICS INC)30,125 股,市值约 US$2.8M,约占其申报组合的 0.62%,在其申报持仓中市值排名第 49 位。 STEMPOINT CAPITAL LP 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)30.12K 股
申报持仓市值$2.79M
组合权重0.62%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

STEMPOINT CAPITAL LP 对 MNPR 的持仓演变

STEMPOINT CAPITAL LP 于 Q2 2026 首次披露 MNPR 持仓:30,125 股(约 US$2.8M)。

逐季持仓明细

季度股数金额变化
Q2 2026 30.12K $2.79M 新进

关于 MNPR 与 13F 数据

MNPR(MONOPAR THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 84 只申报持有 MNPR,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$61.8M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$30.0M), Saturn V Capital Management LP (US$28.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 MNPR 的基金

查看 MNPR 的全部基金持有人 →

常见问题

How long has STEMPOINT CAPITAL LP held MNPR?

STEMPOINT CAPITAL LP has disclosed MNPR holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is STEMPOINT CAPITAL LP's current position in MNPR?

As of Q2 2026, STEMPOINT CAPITAL LP holds 30.12K shares of MNPR (MONOPAR THERAPEUTICS INC), valued at $2.79M, representing 0.62% of its reported portfolio and ranking #49.

Has STEMPOINT CAPITAL LP been buying or selling MNPR?

In the latest 13F filing (Q2 2026), STEMPOINT CAPITAL LP newly opened its position in MNPR.

Which other funds hold MNPR?

Other major institutional holders of MNPR include RA CAPITAL MANAGEMENT, L.P., DEERFIELD MANAGEMENT COMPANY, L.P., Saturn V Capital Management LP, among 84 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.